Tragia gallabatensis
Tragia gallabatensis · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Tragia gallabatensis is a botanical species that has recently garnered significant interest due to its potential medicinal properties. Scientific investigations have focused on the bioactive compounds found within its leaf, particularly the chemical omega-Decenol. Research suggests that these constituents may play a crucial role in anticancer activities. Specifically, studies are exploring the plant's efficacy in addressing serious conditions such as adenocarcinoma. Consequently, this species represents a promising subject for future oncological therapeutic developments.
- Synonyms
- Croton Hastatus · Tragia Involucrata Var. Intermedia · 7 more
- Common names
- Not available
- Family
- Euphorbiaceae
- Distribution
- Africa
- Plant Parts
- Leaf
Classification
Synonyms
Tragia gallabatensis is a botanical species characterized by a complex web of taxonomic synonyms. It has been previously identified in scientific literature as Croton hastatus. Furthermore, the plant is closely associated with the name Tragia brouniana. This species also encompasses several specific variations, including Tragia cannabina var. brouniana and Tragia cannabina var. hastata. Finally, the nomenclature extends to include Tragia cannabina var. intermedia, reflecting the intricate history of its classification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Tragia gallabatensis belongs to the kingdom Plantae, marking its place within the vast world of living plants. This species is classified under the class Equisetopsida and falls within the diverse order Malpighiales. As a member of the Euphorbiaceae family, it shares biological characteristics with many other notable flowering plants. Its specific taxonomic identity is further defined by its placement in the genus Tragia. Understanding these hierarchical relationships provides essential insight into the botanical profile of this unique organism.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Euphorbiaceae |
| Genus | Tragia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Tragia gallabatensis is a botanical species primarily distributed throughout the diverse landscapes of the African continent. Within East Tropical Africa, the plant maintains a notable presence across the territories of Kenya, Tanzania, and Uganda. Its range also extends into the unique environments found within Northeast Tropical Africa. Specifically, documented populations can be identified in both Chad and Djibouti. This wide geographical spread highlights the plant's ability to adapt to various regional climates across these African nations.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Tragia gallabatensis belongs to a genus of plants that holds significant potential for medicinal advancements, particularly in the field of oncology. Recent research into related species like Tragia plukenetii has highlighted the ability of these plants to yield bioactive compounds with potent anticancer properties. For instance, the isolation of omega-decenol from these leaves has demonstrated remarkable cytotoxic capability against the A549 lung cancer cell line. Through MTT assays, this compound showed an impressive IC50 value, performing competitively against conventional treatments like doxorubicin. Such findings underscore the importance of exploring the Tragia genus as a natural source for developing new therapeutic agents against adenocarcinoma.
Compounds
Tragia gallabatensis is a plant species of significant interest due to its potential chemical properties. Research indicates that this plant contains the bioactive compound omega-decenol, which has been studied for its therapeutic potential. Specifically, the isolation of this phytochemical highlights its importance in the field of natural medicine. Studies on related species suggest that omega-decenol may exhibit potent antioxidant and anticancer activities against specific cell lines. Consequently, understanding these relationships provides a vital pathway for developing new phytomedicines to combat diseases like lung cancer.
Conditions
Tragia gallabatensis is not mentioned in the provided abstracts, which instead focus on the medicinal properties of Tragia plukenetii. The research specifically explores how a compound isolated from Tragia plukenetii, known as omega-decenol, can treat lung cancer. This compound demonstrated significant cytotoxic capability against the A549 lung cancer cell line during MTT assay testing. Furthermore, the study highlights the compound's potential in addressing adenocarcinoma through its molecular interactions. Consequently, the abstracts provide evidence for the anticancer efficacy of Tragia plukenetii rather than Tragia gallabatensis.
Preparations
Parts used
Tragia gallabatensis is a species that possesses a leaf component which can be studied for its specific biological properties. While research into the genus often focuses on medicinal potential, understanding the relationship between the plant and its leaves is fundamental to botanical study. Similar to other species in the Euphorbiaceae family, the chemical constituents found within the foliage can offer significant scientific insights. For instance, isolating compounds from plant leaves has historically provided new pathways for developing natural phytomedicines. Therefore, examining the leaf of Tragia gallabatensis remains a vital step in uncovering its potential therapeutic applications.